Chen Schor - Net Worth and Insider Trading
Chen Schor Net Worth
The estimated net worth of Chen Schor is at least $852,008 dollars as of 2024-12-26. Chen Schor is the President and CEO of resTORbio Inc and owns about 270,337 shares of resTORbio Inc (TORC) stock worth over $616,368. Chen Schor is also the President & CEO of Adicet Bio Inc and owns about 250,654 shares of Adicet Bio Inc (ACET) stock worth over $235,640. Details can be seen in Chen Schor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chen Schor has not made any transactions after 2023-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chen Schor
Chen Schor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chen Schor owns 4 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) , Madrigal Pharmaceuticals Inc (MDGL) , and Karyopharm Therapeutics Inc (KPTI) among others .
Click here to see the complete history of Chen Schor’s form 4 insider trades.
Insider Ownership Summary of Chen Schor
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2011-08-22 | director |
| MDGL | Madrigal Pharmaceuticals Inc | 2015-09-16 | director & President and CEO |
| KPTI | Karyopharm Therapeutics Inc | 2020-11-25 | director |
 | | 2023-10-02 | director & See Remarks |
Chen Schor Latest Holdings Summary
Chen Schor currently owns a total of 2 stocks. Among these stocks, Chen Schor owns 270,337 shares of resTORbio Inc (TORC) as of April 16, 2018, with a value of $616,368 and a weighting of 72.34%. Chen Schor also owns 250,654 shares of Adicet Bio Inc (ACET) as of October 2, 2023, with a value of $235,640 and a weighting of 27.66%.
Latest Holdings of Chen Schor
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TORC | resTORbio Inc | 2018-04-16 | 270,337 | 2.28 | 616,368 |
| ACET | Adicet Bio Inc | 2023-10-02 | 250,654 | 0.94 | 235,640 |
Holding Weightings of Chen Schor
Chen Schor Form 4 Trading Tracker
According to the SEC Form 4 filings, Chen Schor has made a total of 0 transactions in resTORbio Inc (TORC) over the past 5 years. The most-recent trade in resTORbio Inc is the acquisition of 286 shares on April 16, 2018, which cost Chen Schor around $17,900.
According to the SEC Form 4 filings, Chen Schor has made a total of 14 transactions in Adicet Bio Inc (ACET) over the past 5 years, including 1 buys and 13 sells. The most-recent trade in Adicet Bio Inc is the acquisition of 11,000 shares on October 2, 2023, which cost Chen Schor around $15,180.
Insider Trading History of Chen Schor
- 1
Chen Schor Trading Performance
GuruFocus tracks the stock performance after each of Chen Schor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chen Schor is 11.25%. GuruFocus also compares Chen Schor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chen Schor within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chen Schor's insider trading performs compared to the benchmark.
Performance of Chen Schor
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.18 | | | | | |
| Relative Return to S&P 500(%) | 17.16 | | | | | |
Chen Schor Ownership Network
Chen Schor Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Chen Schor is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Chen Schor made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Chen Schor Mailing Address
Above is the net worth, insider trading, and ownership report for Chen Schor. You might contact Chen Schor via mailing address: Predix Pharmaceuticals Holdings, Inc., 4 Maguire Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
